Public research preview
Christopher L. Jacobs, Representative disclosure: eb nce Vaxcyte, Inc. - Common Stock (PCVX)
Disclosed a buy transaction in eb nce Vaxcyte, Inc. - Common Stock (PCVX). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 12 Dec 2022, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 34 days
Timeline
Transaction date
8 Nov 2022
Public disclosure
12 Dec 2022
Now
Tracked today
Filing delay: 34 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 9 Jun 2026
Stock path
PCVX from pre-transaction context through latest close.
Bought
8 Nov 2022 · 44,8 USD
- Observed transaction close
- 44,8
- Observed disclosure close
- 44,18
- Observed latest close
- 46,88
- Pre-disclosure move
- -1.4%
- Post-disclosure move
- +6.1%
- Market-adjusted move
- +6.1%
Why Copy Window is Probably too late
Supporting factors
- Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 12 Dec 2022, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%